tiprankstipranks
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (GZPHF)
OTHER OTC:GZPHF
US Market

Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF) Income Statement

Compare
3 Followers

Guangzhou Baiyunshan Pharmaceutical Holdings Company Income Statement

Last quarter (Q3 2024), Guangzhou Baiyunshan Pharmaceutical Holdings Company's total revenue was ¥18.02B, a decrease of -1.08% from the same quarter last year. In Q3, Guangzhou Baiyunshan Pharmaceutical Holdings Company's net income was ¥609.41M. See Guangzhou Baiyunshan Pharmaceutical Holdings Company’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 75.52B¥ 70.79B¥ 69.01B¥ 61.67B¥ 64.95B
Gross Profit
¥ 14.19B¥ 13.28B¥ 13.23B¥ 10.44B¥ 12.87B
Operating Expenses
¥ 9.07B¥ 8.73B¥ 8.85B¥ 6.96B¥ 8.81B
Depreciation and Amortization
¥ 929.44M¥ 743.83M¥ 676.99M¥ 644.20M¥ 591.89M
EBITDA
¥ 6.49B¥ 5.00B¥ 5.82B¥ 4.68B¥ 3.90B
Operating Income
¥ 5.12B¥ 5.07B¥ 4.79B¥ 3.67B¥ 4.06B
Other Income/Expenses
¥ -10.40M¥ -31.16M¥ -62.97M¥ 66.67M¥ 73.52M
Pretax Income
¥ 5.11B¥ 5.04B¥ 4.72B¥ 3.74B¥ 4.13B
Net Income
¥ 4.06B¥ 3.97B¥ 3.72B¥ 2.92B¥ 3.19B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 2.49¥ 2.44¥ 2.29¥ 1.79¥ 1.96
Diluted EPS
¥ 2.49¥ 2.44¥ 2.29¥ 1.79¥ 1.96
Weighted Average Shares Outstanding
1.63B 1.63B 1.63B 1.63B 1.63B
Weighted Average Shares Outstanding (Diluted)
1.63B 1.63B 1.63B 1.63B 1.63B
Currency in CNY

Guangzhou Baiyunshan Pharmaceutical Holdings Company Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis